Cancer treatment of severely-III patients not eligible for chemotherapy

Despite having disseminated cancer, not all patients are eligible for palliative chemotherapy or targeted therapies. To study reasons for withholding palliative chemotherapy, to survey which alternatives were offered and to study survival outcomes. Medical records of 346 patients with disseminated c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anticancer research 2013-12, Vol.33 (12), p.5639-5643
Hauptverfasser: Randén, Margareta, Runesdotter, Sara, Strang, Peter
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Despite having disseminated cancer, not all patients are eligible for palliative chemotherapy or targeted therapies. To study reasons for withholding palliative chemotherapy, to survey which alternatives were offered and to study survival outcomes. Medical records of 346 patients with disseminated cancer were collected. Univariate and multivariate statistics were applied. In total, 48% (n=164) of patients were not offered palliative chemotherapy, mainly depending on diagnosis, age and performance status. Instead, palliative radiotherapy (44%) or endocrine treatments (25%) (breast and prostate cancer) were prescribed. The mean survival for these patients was 216 days, with median survival of only 77 days. In the Cox multivariate analysis survival, prospects were better if the patient was ambulatory and living at home at the first consultation (p
ISSN:1791-7530
0250-7005
1791-7530